Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina
NCT ID: NCT03923153
Last Updated: 2021-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2019-04-15
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training in Pulmonary Hypertension
NCT03385733
Acute Effects of Inspiratory Muscle Training at Different Intensities in Healthy People
NCT03788356
Inspiratory Muscle Training in Heart Failure
NCT04839211
Effects of Inspiratory Muscle Training in Patients With Post COVID-19
NCT05231395
Effects of Wrestling Training on Psychological Well-Being, Anxiety, and Resilience in Adolescent Sedanter Boys
NCT07193121
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inspiratory muscle training group
Inspiratory muscle training group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device
Inspiratory muscle training with PowerBreathe (IMT Technologies Ltd., Birmingham,England)
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP).
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.
Sham group
Sham group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device
Sham group with PowerBreathe (IMT Technologies Ltd., Birmingham, England)
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 10% of maximal inspiratory pressure (MIP).
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inspiratory muscle training with PowerBreathe (IMT Technologies Ltd., Birmingham,England)
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP).
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.
Sham group with PowerBreathe (IMT Technologies Ltd., Birmingham, England)
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 10% of maximal inspiratory pressure (MIP).
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anjina patients who are clinically stable
* have no other disease that may affect respiratory function
* Individuals who have the good cooperation
Exclusion Criteria
* Pregnancy
* Active infection
* Patients with known malignancies
* patients without consent
* known arrhythmia, dilated or hypertrophic cardiomyopathy, heart failure (EF \<40%)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mustafa Kemal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Irem Hüzmeli
lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aysel yıldız, assoc prof
Role: STUDY_DIRECTOR
Marmara University Faculty of Health Sciences
Irem Hüzmeli, Msc
Role: STUDY_CHAIR
Mustafa Kemal University
Oğuz Akkuş, assist prof
Role: PRINCIPAL_INVESTIGATOR
hatay mustafa kemal university Faculty of Medicine
Fatih Yalçın, Prof.
Role: STUDY_CHAIR
hatay mustafa kemal university Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hatay Mustafa Kemal University
Hatay, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kellens I, Cannizzaro F, Gouilly P, Crielaard JM. [Inspiratory muscles strength training in recreational athletes]. Rev Mal Respir. 2011 May;28(5):602-8. doi: 10.1016/j.rmr.2011.01.008. Epub 2011 Apr 19. French.
Long L, Anderson L, Dewhirst AM, He J, Bridges C, Gandhi M, Taylor RS. Exercise-based cardiac rehabilitation for adults with stable angina. Cochrane Database Syst Rev. 2018 Feb 2;2(2):CD012786. doi: 10.1002/14651858.CD012786.pub2.
American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624. doi: 10.1164/rccm.166.4.518. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MustafaKU 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.